Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,999 | 1,610 | 1,789 | 2,174 | 4,465 |
| Gross Profit | 1,999 | 1,610 | 1,789 | 2,174 | 4,465 |
| Operating Expenses | 26,598 | 28,723 | 24,693 | 25,093 | 23,481 |
| Operating Income | -24,599 | -27,113 | -22,904 | -22,919 | -19,016 |
| Other Income | 68 | 68 | 73 | 63 | -11 |
| Pre-tax Income | -24,531 | -27,045 | -22,831 | -22,856 | -19,027 |
| Net Income Continuous | -24,531 | -27,045 | -22,831 | -22,856 | -19,027 |
| Net Income | $-24,531 | $-27,045 | $-22,831 | $-22,856 | $-19,027 |
| EPS Basic Total Ops | -0.68 | -0.75 | -0.64 | -0.64 | -0.09 |
| EPS Basic Continuous Ops | -0.68 | -0.75 | -0.64 | -0.64 | -5.90 |
| EPS Diluted Total Ops | -0.68 | -0.75 | -0.64 | -0.64 | -0.09 |
| EPS Diluted Continuous Ops | -0.68 | -0.75 | -0.64 | -0.64 | -5.90 |
| EBITDA(a) | $-22,919 | $-26,725 | $-22,534 | $-22,560 | $-18,669 |